MUNICH–(BUSINESS WIRE)–EMA grants orphan drug designation for Isarna’s ISTH0036, a LNA-modified antisense oligonucleotide targeting TGF-β2, for the prevention of scarring post trabeculectomy in glaucoma.
Author: Business Wire
Bruker Announces Resignation of Chief Financial Officer and Appointment of Interim Chief Financial Officer
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, submitted his resignation, …
Optikos CEO, Stephen D. Fantone Receives University of Rochester Distinguished Scholar Award
WAKEFIELD, Mass.–(BUSINESS WIRE)–Optikos CEO, Stephen D. Fantone, receives Rochester Distinguished Scholar Award at the University’s 2015 Doctoral Ceremony.
BioTime to Present at the Jefferies 2015 Global Healthcare Conference
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX) today announced that Chief Executive Officer Michael D. West, PhD will present at the Jefferies 2015 Global Healthcare Conference to be held in New York on June 1-4, 2015. Dr. West will pr…
Study: Comprehensive Eye Exams Can Help Re-Engage Patients into Care for Certain Chronic Conditions, with the Potential to Help Improve Health and Reduce Costs
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare study: comprehensive eye exams can help re-engage patients into care for certain chronic conditions, with the potential to help improve health and reduce costs.
pSivida Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida reports positive IOP Safety Data in Phase III Trial of Medidur for Posterior Uveitis
U.K. Ophthalmologists Lead in Treatment of Wet AMD Patients with Oraya Therapy Across Europe
NEWARK, Calif. & LIVERPOOL, England–(BUSINESS WIRE)–Oraya Therapeutics Inc. announced today at the Royal College of Ophthalmologists Annual Congress that U.K. ophthalmologists are the leading adopters of Oraya Therapy for the treatment of wet age-related macular degeneration (AMD), two years after the treatment was introduced in the country. Sheffield Teaching Hospitals NHS Foundation Trust alone has treated more than 150 patients in the year since the service was commissioned, with other Nat
Acucela Nominates Shintaro Asako to Its Board of Directors
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, has announced that it has nominated Shintaro Asako to stand for election to the Company’s Board of Directors (the “Board”) at the 2015 Annual Meeting of Shareholders on June 25, 2015 (the “Annual Meeting”) at Acucela’s he
Ocata Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), a leader in the field of regenerative ophthalmology, today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015 at 2:00 p.m. EDT in New York City. A live audio webcast of the presentation will be available via the “Investor Relations” page of the Ocata website, www.ocata.com. A repla
Allegro Ophthalmics Announces Issuance of U.S. Patent for First-in-Class Integrin Peptide Therapy Candidate Luminate®
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–Allegro Ophthalmics, LLC, announced that the USPTO has issued US Patent 9,018,352 covering the composition of matter of Allegro’s product candidate Luminate (ALG-1001).
R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate Scho…
Modernizing Medicine Incorporates American Urological Associations Choosing Wisely Guidelines into Its Electronic Medical Records System
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine, the creator of the Electronic Medical Assistant® (EMA™), announced today that it has incorporated the American Urological Association’s 2013 Choosing Wisely® list in EMA Urology.
Modernizing Medicine Showcases EMA Gastroenterology EMR System at Annual Digestive Disease Week 2015
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), showcases EMA Gastroenterology at Digestive Disease Week Annual Conference in Washington, D.C.
Technavio Publishes Industry Analysis Report on the Medical Laser Systems Market 2015-2019
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the global medical laser systems market, which is expected to grow at a CAGR of 13% from 2015-2019.
Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of Post-Surgical Ocular Pain Indication; Reports First Quarter 2015 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for …
Company Profile for Iris Pharma
–(BUSINESS WIRE)–A leading CRO dedicated to ophthalmology, Iris Pharma partners with clients to carry out preclinical and clinical studies involving all areas of the field.
Bruker Secures Major Contract for DE-tector™ Explosives Trace Detector
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today announced that it has secured a contract for the supply of one hundred (100) units of the DE-tector™ explosives trace detection (ETD) system for use at selected airports in Germany, including at the international Frankfurt Airport (FRA). This contract award followed the DE-tector system having successfully met the new European Civil Aviation Conference’s (ECAC) Common Evaluation Process of Security Equipment (CEP) for ai
Kala Pharmaceuticals Appoints Mark Iwicki as Executive Chairman
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. today announced the appointment of Mark Iwicki as Executive Chairman and a member of its board of directors.
NovaBay Pharmaceuticals Reports 2015 First Quarter Financial Results and Provides Business Update
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three months ended March 31, 2015, and provided a business update. First Quarter 2015 and Recent Operational and Financial Highlights Grew sales of Avenova™ by 112% to $465,000 in the first quarter of 2015 over the fourth quarter of 201
Acucela Announces Publication of Pre-clinical Data for Emixustat Hydrochloride
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced the publication of pre-clinical data related to the company’s investigational drug candidate, emixustat hydrochloride (emixustat), in the scientific journal PLOS ONE. The published article, “Visual Cycle Modulation as an Approach Towa